Robert K. Doot

2.6k total citations
71 papers, 1.9k citations indexed

About

Robert K. Doot is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert K. Doot has authored 71 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert K. Doot's work include Medical Imaging Techniques and Applications (46 papers), Radiomics and Machine Learning in Medical Imaging (27 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Robert K. Doot is often cited by papers focused on Medical Imaging Techniques and Applications (46 papers), Radiomics and Machine Learning in Medical Imaging (27 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Robert K. Doot collaborates with scholars based in United States, Ireland and Belgium. Robert K. Doot's co-authors include David A. Mankoff, Paul E. Kinahan, Henry Hess, Viola Vogel, John Clemmens, Erin K. Schubert, Brenda F. Kurland, Hannah M. Linden, Mark Muzi and Jennifer M. Specht and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Nano Letters.

In The Last Decade

Robert K. Doot

69 papers receiving 1.9k citations

Peers

Robert K. Doot
Costas Arvanitis United States
R K Jain United States
Herbert H. Engelhard United States
Simon Walker‐Samuel United Kingdom
Douglas W. Laske United States
Laird Miers United States
Ian Y. Chen United States
Costas Arvanitis United States
Robert K. Doot
Citations per year, relative to Robert K. Doot Robert K. Doot (= 1×) peers Costas Arvanitis

Countries citing papers authored by Robert K. Doot

Since Specialization
Citations

This map shows the geographic impact of Robert K. Doot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert K. Doot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert K. Doot more than expected).

Fields of papers citing papers by Robert K. Doot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert K. Doot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert K. Doot. The network helps show where Robert K. Doot may publish in the future.

Co-authorship network of co-authors of Robert K. Doot

This figure shows the co-authorship network connecting the top 25 collaborators of Robert K. Doot. A scholar is included among the top collaborators of Robert K. Doot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert K. Doot. Robert K. Doot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miranda, Alan, Jeroen Verhaeghe, Filipe Elvas, et al.. (2024). Biodistribution and dosimetry of the PET radioligand [18F]CHDI-650 in mice for detection of mutant huntingtin aggregates. EJNMMI Research. 14(1). 126–126.
2.
Pantel, Austin R., Mahsa Kiani, Robert K. Doot, et al.. (2024). Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate–Ribose) Polymerase-1–Targeted18F-Fluorthanatrace PET in Breast Cancer. Journal of Nuclear Medicine. 65(12). jnumed.124.268254–jnumed.124.268254. 2 indexed citations
3.
Lee, Hsiaoju, Sally W. Schwarz, Erin K. Schubert, et al.. (2022). The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1. Radiology Imaging Cancer. 4(1). e210070–e210070. 14 indexed citations
4.
Doot, Robert K., Ilya M. Nasrallah, Reagan R. Wetherill, et al.. (2022). [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s Disease. Cells. 11(19). 3081–3081. 7 indexed citations
5.
Tu, Vincent, Hsiaoju Lee, Kyle Bittinger, et al.. (2022). Imaging sensitive and drug-resistant bacterial infection with [11C]-trimethoprim. Journal of Clinical Investigation. 132(18). 22 indexed citations
6.
Pantel, Austin R., Varsha Viswanath, Mark Muzi, Robert K. Doot, & David A. Mankoff. (2022). Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions. Journal of Nuclear Medicine. 63(4). 514–521. 7 indexed citations
7.
Nabavizadeh, Ali, Stephen Bagley, Robert K. Doot, et al.. (2022). Distinguishing Progression from Pseudoprogression in Glioblastoma Using18F-Fluciclovine PET. Journal of Nuclear Medicine. 64(6). 852–858. 18 indexed citations
8.
McDonald, Elizabeth S., Austin R. Pantel, Payal D. Shah, et al.. (2021). In vivo visualization of PARP inhibitor pharmacodynamics. JCI Insight. 6(8). 24 indexed citations
9.
Viswanath, Varsha, Austin R. Pantel, Margaret E. Daube-Witherspoon, et al.. (2020). Quantifying Bias and Precision of Kinetic Parameter Estimation on the PennPET Explorer, a Long Axial Field-of-View Scanner. IEEE Transactions on Radiation and Plasma Medical Sciences. 4(6). 735–749. 18 indexed citations
10.
McDonald, Elizabeth S., Robert K. Doot, Erin K. Schubert, et al.. (2019). Breast Cancer18F-ISO-1 Uptake as a Marker of Proliferation Status. Journal of Nuclear Medicine. 61(5). 665–670. 29 indexed citations
11.
Doot, Robert K., et al.. (2018). Selectivity of probes for PET imaging of dopamine D3 receptors. Neuroscience Letters. 691. 18–25. 19 indexed citations
12.
Doot, Robert K., Jacob G. Dubroff, Joshua Scheuermann, et al.. (2018). Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride. EJNMMI Physics. 5(1). 21–21. 6 indexed citations
14.
Dubroff, Jacob G., Robert K. Doot, Mary Falcone, et al.. (2015). Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. Journal of Nuclear Medicine. 56(11). 1724–1729. 24 indexed citations
16.
Doot, Robert K., et al.. (2014). Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements. Translational Oncology. 7(1). 48–54. 26 indexed citations
17.
Harrison, Robert L., et al.. (2014). A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment. Translational Oncology. 7(1). 138–146. 10 indexed citations
18.
Yu, Evan Y., Fenghai Duan, Mark Muzi, et al.. (2013). Effects of dasatinib on prostate cancer bone metastases and normal bone measured by 18F-fluoride PET: Preliminary results from ACRIN 6687. 54(4). 289–289. 2 indexed citations
19.
Doot, Robert K., Brenda F. Kurland, Paul E. Kinahan, & David A. Mankoff. (2011). Design Considerations for using PET as a Response Measure in Single Site and Multicenter Clinical Trials. Academic Radiology. 19(2). 184–190. 27 indexed citations
20.
Partridge, Savannah C., Robert K. Doot, Xiaoyu Chai, et al.. (2010). Association between serial dynamic contrast‐enhanced MRI and dynamic 18F‐FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer. Journal of Magnetic Resonance Imaging. 32(5). 1124–1131. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026